Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and president of Renown Institute for Health Innovation, discusses the impact of the latest milestone in the Healthy Nevada Project: Notifying participants who are at risk for certain genetic conditions.
The Healthy Nevada Project — our community’s groundbreaking population health study — is now reaching out to study participants who asked to be notified about specific health risks. The genetic study is led by Renown Institute for Health Innovation (Renown IHI) – a collaboration between Renown and the Desert Research Institute.
We’re focusing on the Centers for Disease Control’s Tier One genetic conditions, which include familial hypercholesterolemia, BRCA and Lynch syndrome. If study volunteers choose, the project will also provide guidance on treatment and testing for potentially at-risk family members.
Healthy Nevada, Healthy Community
The return of results for the Healthy Nevada Project means two things — one for the community, another for the individual. For the community at large, the study helps us better understand the big picture. We’re getting an understanding about the kinds of genetically programmed diseases we have locally and their prevalence. Furthermore, we’re able to ask the question: Are there characteristics in our community that are leading to a higher or lower prevalence of those conditions? And for the individual, the return of those results can be life-changing.
Dr. Anthony Slonim is an innovator and proven leader in healthcare on both the regional and national levels. During his notable career at major healthcare organizations and academic institutions, Dr. Slonim has developed a national profile as an expert in patient safety, accountable care, healthcare quality and innovative care delivery models focused on improving health within the community. For more Healthy Perspectives, follow Dr. Slonim on Twitter.